Deprenyl

Selegiline A selective, irreversible inhibitor of Type B monoamine oxidase. It is used in newly diagnosed patients with Parkinson's disease. It may slow progression of the clinical disease and delay the requirement for levodopa therapy. It also may be given with levodopa upon onset of disability. (From AMA Drug Evaluations Annual, 1994, p385) The compound without isomeric designation is Deprenyl.

Molecular Formula: C₁₃H₁₇N

InChI: InChI=1/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3

InChIKey: InChIKey=MEZLKOACVSPNER-UHFFFAOYAT
SMILES: CC(CC1=CC=CC=C1)N(C)CC#C

Names:
    Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl- (9CI)
    Deprenil
    Deprenyl
    N,alpha-Dimethyl-N-2-propynylbenzeneethanamine
    N,alpha-Dimethyl-N-2-propynylphenethylamine
    N-methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine
    PHENETHYLAMINE, N,alpha-DIMETHYL-N-2-PROPYNYL-
    (+-)-Deprenyl
    2323-36-6

Registries:
    PubChem CID 5195
    PubChem ID 160070